Anti-venom Market By Product Type (Polyvalent Anti-venom, Monovalent Anti-venom), By Species (Snake Anti-venom, Scorpion Anti-venom, Spider Anti-venom, Marine Anti-venom, Others), By Source (Equine-based Anti-venom, Ovine-based Anti-venom, Others), By Mode of Administration (Intravenous, Intramuscular, Subcutaneous, Others), and By End-User (Hospitals, Clinics, Poison Control Centers, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Polyvalent Anti-venom
  • Monovalent Anti-venom

By Species

• Snake Anti-venom
• Scorpion Anti-venom
• Spider Anti-venom
• Marine Animal Anti-venom
• Others

By Source

• Equine-based Anti-venom
• Ovine-based Anti-venom
• Others

By Mode of Administration

• Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
• Others

By End-User

• Hospitals
• Clinics
• Poison Control Centers
• Others

By Region

North America

• The U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Baxter International Inc.
• Pfizer Inc.
• Sanofi S.A.
• Haffkine Bio-Pharmaceutical Corporation Ltd.
• Serum Institute of India Pvt. Ltd.
• Venomtech Ltd.
• Bioclon Institute
• Merial
• Instituto Biologico de Sao Paulo
• LifeSaver
• Lanchang Jinhai Biopharmaceutical Co. Ltd.
• Mynvax Pvt. Ltd.
• Grifols S.A.
• Indian Immunologicals Ltd.
• King Cobra Biotech
• Swan BioScience
• VINS Bioproducts Limited
• Bharat Serums and Vaccines Ltd.